Larimar Therapeutics Inc. (LRMR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Larimar Therapeutics Inc.

    NASDAQ: LRMR · Real-Time Price · USD
    4.87
    0.59 (13.79%)
    At close: Oct 03, 2025, 3:59 PM
    4.84
    -0.62%
    After-hours: Oct 03, 2025, 07:55 PM EDT

    Larimar Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 33.22M 26.75M 26.82M 70.1M
    Short-Term Investments
    		 150.24M 60.04M 91.6M n/a
    Long-Term Investments
    		 n/a 1.34M 1.34M 1.34M
    Other Long-Term Assets
    		 1.2M 659K 638K 669K
    Receivables
    		 1.05M n/a n/a 208K
    Inventory
    		 n/a n/a n/a -208K
    Other Current Assets
    		 10.8M 709K n/a 279K
    Total Current Assets
    		 195.3M 90.17M 120.74M 72.2M
    Property-Plant & Equipment
    		 3.72M 3.76M 3.69M 4.46M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 4.92M 5.76M 5.67M 6.46M
    Total Assets
    		 200.22M 95.94M 126.41M 78.67M
    Account Payables
    		 2.42M 1.28M 1.69M 1.66M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 611K 594K
    Other Current Liabilities
    		 n/a n/a 5.75M 4.9M
    Total Current Liabilities
    		 24.36M 9.51M 10.71M 8.85M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 4.06M 4.71M 4.8M 5.41M
    Total Liabilities
    		 28.41M 14.21M 15.5M 14.25M
    Total Debt
    		 5.12M 5.55M 5.41M 6M
    Book Value
    		 171.81M 81.72M 110.9M 64.41M
    Book Value Per Share
    		 2.80 1.86 4.31 3.75
    Common Stock
    		 64K 43K 43K 18K
    Retained Earnings
    		 -269.16M -188.55M -151.6M -116.25M
    Comprehensive Income
    		 148K 81K -31K -0.00
    Shareholders Equity
    		 171.81M 81.72M 110.9M 64.41M
    Total Investments
    		 150.24M 61.38M 91.6M 1.34M

    Add to Watchlist